Kim, Seok Jin

This study is for people with primary central nervous system (CNS) lymphoma who have finished initial treatment but cannot have a stem cell transplant. The goal is to see if a maintenance therapy with two drugs, lenalidomide and rituximab, can keep the cancer from coming back and…

This study tests whether adding a third drug (cytarabine) to the standard two-drug chemo regimen can help older adults with mantle cell lymphoma live longer without their cancer growing. The trial enrolls 90 patients aged 70+ (or 60+ if not eligible for transplant) who have not y…